Gengyun C Le-Chan

Dr. Gengyun C Le-Chan

Biology, University of Hartford, West Hartford, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Cell Stem Cell
Verified
Journal Article
Closed access
SCSunny Sun-Kin Chan
Sunny Sun-Kin Chan
XSXiaozhong Shi
Xiaozhong Shi
ATAkira Toyama
Akira Toyama
RARobert W. Arpke
Robert W. Arpke
ADAbhijit Dandapat
Abhijit Dandapat
MKMichael Kyba
Michael Kyba

1 January 2019 in Experimental Gerontology
Verified
Journal Article
Closed access
CCChristine A. Cabelka
Christine A. Cabelka
CBCory W. Baumann
Cory W. Baumann
BCBrittany C. Collins
Brittany C. Collins
NNNardina Nash
Nardina Nash
Gengyun C Le-ChanGengyun C Le-Chan
Gengyun C Le-Chan
DLDawn A. Lowe
Dawn A. Lowe

24 August 2018 in The Journal of Physiology
Verified
Journal Article
Closed access
PDF file
Gengyun C Le-ChanGengyun C Le-Chan
Gengyun C Le-Chan
SNSusan A. Novotny
Susan A. Novotny
TMTara L. Mader
Tara L. Mader
SGSarah M. Greising
Sarah M. Greising
SCSunny S. K. Chan
Sunny S. K. Chan
GWGordon Warren
Gordon Warren

6 August 2016
Verified
Book Chapter
Closed access
PDF file
Gengyun C Le-ChanGengyun C Le-Chan
Gengyun C Le-Chan
DLDawn A. Lowe
Dawn A. Lowe
MKMichael Kyba
Michael Kyba

1 July 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
Gengyun C Le-ChanGengyun C Le-Chan
Gengyun C Le-Chan
HEH.C. Essackjee
H.C. Essackjee
HBH.J. Ballard
H.J. Ballard

25 January 2025 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
GKGeorgios Kararigas
Georgios Kararigas
MEMara C. Ebeling
Mara C. Ebeling
Gengyun C Le-ChanGengyun C Le-Chan
Gengyun C Le-Chan
SLShaojuan Lai
Shaojuan Lai
CCChunmei Cui
Chunmei Cui
DLDawn A. Lowe
Dawn A. Lowe
Background: With a decline of 17β‐estradiol (E2) at menopause, E2 has been implicated in the accompanied loss of skeletal muscle mass and strength. We aimed at characterizing transcriptomic responses of skeletal muscle to E2 in female mice, testing the hypothesis that genes and pathways related to contraction and maintenance of mass are differentially expressed in ovariectomized mice with and without E2 treatment. Methods: Soleus and tibialis anterior (TA) muscles from C57BL/6 ovariectomized mice treated with placebo (OVX) or E2 (OVX + E2) for 60 days, or from skeletal muscle‐specific ERα knockout (skmERαKO) mice and wild‐type littermates (skmERαWT), were used for genome‐wide expression profiling, quantitative real‐time PCR and immunoblotting. Computational detection of estrogen response elements (EREs) was performed with EREFINDER. Results: We found 155 significantly regulated probe sets in response to E2 ( p ≤ 0.001). Pathway analyses identified proteasome and ubiquitin‐mediated proteolysis as two downregulated pathways in the E2 group. We confirmed downregulation ( p ≤ 0.05) in levels of Fbxw7 , Psmb6 , Ube2h and Ubxn1 , as well as pro‐apoptotic Bnip3 and inflammatory factor Nfkbia . Computational analysis identified ERE in the promoter regions of Psmb6 , Ube2h , Bnip3 and Nfkbia . The overall content of ubiquitinated proteins was modestly but significantly lower in TA muscles from OVX + E2 vs. OVX mice ( p = 0.039). There were no differences between skmERαKO and skmERαWT mice or between skmERαKO/OVX and skmERαKO/OVX + E2 mice for any genes assessed, indicating that ERα is required for E2 regulation of those genes. Conclusions: These results suggest that a mechanism whereby E2 protects against losses of skeletal muscle mass and strength is regulation of ubiquitin‐proteasomal mediators.